Literature DB >> 32030301

Definitive chemoradiotherapy with simultaneous integrated boost of radiotherapy dose for T4 esophageal cancer-will it stand for a standard treatment?

Satoru Matsuda1, Shuhei Mayanagi1, Tomoyuki Irino1, Hirofumi Kawakubo1, Yuko Kitagawa1.   

Abstract

Year:  2019        PMID： 32030301      PMCID： PMC6988050          DOI： 10.21037/jtd.2019.12.59

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  20 in total

1.  Phase II feasibility study of preoperative chemotherapy with docetaxel, cisplatin, and fluorouracil for esophageal squamous cell carcinoma.

Authors:  Hiroki Hara; Makoto Tahara; Hiroyuki Daiko; Ken Kato; Hiroyasu Igaki; Shigenori Kadowaki; Yoichi Tanaka; Yasuo Hamamoto; Hisayuki Matsushita; Michitaka Nagase; Yoshinori Hosoya
Journal:  Cancer Sci       Date:  2013-10-18       Impact factor: 6.716

2.  Re-evaluating the optimal radiation dose for definitive chemoradiotherapy for esophageal squamous cell carcinoma.

Authors:  Liru He; Pamela K Allen; Adam Potter; Jingya Wang; Joe Y Chang; Daniel R Gomez; Ritsuko Komaki; Zhongxing Liao; Steven H Lin
Journal:  J Thorac Oncol       Date:  2014-09       Impact factor: 15.609

3.  Phase I/II study of docetaxel, cisplatin, and 5-fluorouracil combination chemoradiotherapy in patients with advanced esophageal cancer.

Authors:  Tatsuya Miyazaki; Makoto Sohda; Naritaka Tanaka; Shigemasa Suzuki; Keisuke Ieta; Makoto Sakai; Akihiko Sano; Takehiko Yokobori; Takanori Inose; Masanobu Nakajima; Minoru Fukuchi; Hitoshi Ojima; Hiroyuki Kato; Hiroyuki Kuwano
Journal:  Cancer Chemother Pharmacol       Date:  2014-12-28       Impact factor: 3.333

4.  Intensity-modulated proton therapy further reduces normal tissue exposure during definitive therapy for locally advanced distal esophageal tumors: a dosimetric study.

Authors:  James Welsh; Daniel Gomez; Matthew B Palmer; Beverly A Riley; Amin V Mayankkumar; Ritsuko Komaki; Lei Dong; X Ronald Zhu; Anna Likhacheva; Zhongxing Liao; Wayne L Hofstetter; Jaffer A Ajani; James D Cox
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-04-04       Impact factor: 7.038

5.  Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial.

Authors:  Joel Shapiro; J Jan B van Lanschot; Maarten C C M Hulshof; Pieter van Hagen; Mark I van Berge Henegouwen; Bas P L Wijnhoven; Hanneke W M van Laarhoven; Grard A P Nieuwenhuijzen; Geke A P Hospers; Johannes J Bonenkamp; Miguel A Cuesta; Reinoud J B Blaisse; Olivier R C Busch; Fiebo J W Ten Kate; Geert-Jan M Creemers; Cornelis J A Punt; John Th M Plukker; Henk M W Verheul; Ernst J Spillenaar Bilgen; Herman van Dekken; Maurice J C van der Sangen; Tom Rozema; Katharina Biermann; Jannet C Beukema; Anna H M Piet; Caroline M van Rij; Janny G Reinders; Hugo W Tilanus; Ewout W Steyerberg; Ate van der Gaast
Journal:  Lancet Oncol       Date:  2015-08-05       Impact factor: 41.316

6.  Involved-field irradiation in definitive chemoradiotherapy for T4 squamous cell carcinoma of the esophagus.

Authors:  M Li; F Zhao; X Zhang; F Shi; H Zhu; A Han; Y Zhang; L Kong; J Yu
Journal:  Curr Oncol       Date:  2016-04-13       Impact factor: 3.677

7.  Failure patterns in patients with esophageal cancer treated with definitive chemoradiation.

Authors:  James Welsh; Stephen H Settle; Arya Amini; Lianchun Xiao; Akihiro Suzuki; Yuki Hayashi; Wayne Hofstetter; Ritsuko Komaki; Zhongxing Liao; Jaffer A Ajani
Journal:  Cancer       Date:  2011-10-05       Impact factor: 6.860

8.  Phase II study of chemoselection with docetaxel plus cisplatin and 5-fluorouracil induction chemotherapy and subsequent conversion surgery for locally advanced unresectable oesophageal cancer.

Authors:  Tomoya Yokota; Ken Kato; Yasuo Hamamoto; Yasuhiro Tsubosa; Hirofumi Ogawa; Yoshinori Ito; Hiroki Hara; Takashi Ura; Takashi Kojima; Keisho Chin; Shuichi Hironaka; Takayuki Kii; Yasushi Kojima; Yasunori Akutsu; Hisayuki Matsushita; Kentaro Kawakami; Keita Mori; Yushi Nagai; Chika Asami; Yuko Kitagawa
Journal:  Br J Cancer       Date:  2016-11-03       Impact factor: 7.640

9.  Dosimetric comparison between proton beam therapy and photon radiation therapy for locally advanced esophageal squamous cell carcinoma.

Authors:  Yasuhiro Hirano; Masakatsu Onozawa; Hidehiro Hojo; Atsushi Motegi; Sadatomo Zenda; Kenji Hotta; Shunsuke Moriya; Hidenobu Tachibana; Naoki Nakamura; Takashi Kojima; Tetsuo Akimoto
Journal:  Radiat Oncol       Date:  2018-02-09       Impact factor: 3.481

Review 10.  Treatment and clinical outcome of clinical T4 esophageal cancer: A systematic review.

Authors:  Tomoki Makino; Makoto Yamasaki; Koji Tanaka; Yasuhiro Miyazaki; Tsuyoshi Takahashi; Yukinori Kurokawa; Masaaki Motoori; Yutaka Kimura; Kiyokazu Nakajima; Masaki Mori; Yuichiro Doki
Journal:  Ann Gastroenterol Surg       Date:  2018-12-13
View more
  1 in total

1.  A retrospective study comparing definitive chemoradiotherapy vs. chemoradiotherapy followed by surgery in T4 esophageal squamous cell carcinoma patients who were downstaged after neochemoradiotherapy.

Authors:  Tian Zhang; Zhoubo Guo; Xi Chen; Jie Dong; Hongjing Jiang; Peng Tang; Ping Wang; Dong Qian; Wencheng Zhang; Qingsong Pang
Journal:  Radiat Oncol       Date:  2022-08-23       Impact factor: 4.309
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.